In turn, PARP-1 inhibition blocks the poly(ADP-ribosyl)ation of the AP-1 transcription factors c-FOS and c-JUN resulting in p62 downregulation, enhanced CAF activity, and PCa aggressiveness [75]. The gene discussed is FOS; the disease is posterior cortical atrophy.